ClinicalTrials.Veeva

Menu

Ketamine Versus Dexmedetomidine With Local Anesthetic in TAP Block

A

Assiut University

Status and phase

Completed
Phase 3
Phase 2

Conditions

Lower Abdominal Cancer
Postoperative Analgesia

Treatments

Drug: control group
Drug: dexmedetomidine
Drug: Ketamine

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Comparing the analgesic effects of ketamine and dexmedetomidine when added to local anesthetic in TAP block for postoperative analgesia after lower abdominal cancer surgery.

Enrollment

90 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients ASA I and II to whom abdominal surgery for cancer will be conducted will be included in the study

Exclusion criteria

  • Coagulopathies
  • ASA III or IV, patient refusal, sensitivity to the used drugs

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Quadruple Blind

90 participants in 3 patient groups, including a placebo group

control group,
Placebo Comparator group
Description:
saline in the same volume will be added to the local anesthetic for TAP block in patients undergoing abdominal cancer surgery
Treatment:
Drug: dexmedetomidine
Drug: Ketamine
ketamine group,
Active Comparator group
Description:
ketamine in a dose of 0.5mg/kg will be added to the local anesthetic for TAP block in patients undergoing abdominal cancer surgery
Treatment:
Drug: control group
Drug: dexmedetomidine
dexmedetomidine group
Active Comparator group
Description:
dexmedetomidine in a dose of 1ug/kg will be added to the local anesthetic for TAP block in patients undergoing abdominal cancer surgery
Treatment:
Drug: control group
Drug: Ketamine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems